ADRB1 and heart failure: Additionally, in a rat model of heart failure, treatment with the β1-AR blocker bisoprolol post-myocardial infarction increases cytosolic and mitochondrial creatine kinase (CK) activities, which should act to improve ATP transfer and buffering within cardiomyocytes [35].